iodoacetamide has been researched along with Cancer of Liver in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frick, DN; Hanson, AM; Isailovic, D; Kolli, R; Marvin, RK; Mukherjee, S; Ndjomou, J; Schoenen, FJ; Schroeder, CE; Simpson, DS; Sweeney, NL; Weiner, WS | 1 |
Li, K; Macri, J; Malinowski, P; Manocha, M | 1 |
Bekesi, G; Davis, A; Denner, L; Holland, JF; Jiang, JD; Li, JN; Li, Y; Ling, YH; Marcelli, M; Perez-Soler, R; Roboz, J; Wang, LG; Wang, Y | 1 |
Eberts, TJ; Goulding, FJ; Jackson, RC; Weber, G; Williams, JC | 1 |
Fujita, H; Kappas, A; Mitani, K; Sassa, S | 1 |
Kong, V; Kudryk, B; Redman, C; Yu, S | 1 |
6 other study(ies) available for iodoacetamide and Cancer of Liver
Article | Year |
---|---|
Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.
Topics: Antioxidants; Antiviral Agents; Azoles; Carcinoma, Hepatocellular; Cell Proliferation; Electrophoretic Mobility Shift Assay; Hepacivirus; Hepatitis C; Humans; Hydrolysis; Isoindoles; Kinetics; Liver Neoplasms; Models, Molecular; Nucleic Acids; Organoselenium Compounds; Protein Structure, Tertiary; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Tumor Cells, Cultured; Viral Nonstructural Proteins; Virus Replication | 2014 |
Development of a 2-D apoB peptide profile to detect conformational changes associated with apoB-containing lipoproteins.
Topics: Apolipoprotein B-100; Cell Line, Tumor; Dithiothreitol; Electrophoresis, Gel, Two-Dimensional; Glucosamine; Glucose; Humans; Hydrogen-Ion Concentration; Iodoacetamide; Liver Neoplasms; Oleic Acid; Peptide Fragments; Protein Folding; Protein Processing, Post-Translational; Proteome; Reproducibility of Results; Tunicamycin | 2009 |
Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Drug Screening Assays, Antitumor; Humans; Iodoacetamide; Ligands; Liver Neoplasms; Male; Mice; Mice, Nude; Microtubules; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tubulin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; U937 Cells; Vincristine; Xenograft Model Antitumor Assays | 2002 |
Enzymatic markers of neoplastic transformation and regulation of purine and pyrimidine metabolism.
Topics: AMP Deaminase; Animals; Cell Transformation, Neoplastic; Humans; Iodoacetamide; Ischemia; Kidney Neoplasms; Ligases; Liver; Liver Neoplasms; Lymphoma; Male; Neoplasms, Experimental; Nucleoside-Diphosphate Kinase; Pentosephosphates; Purines; Pyrimidines; Rats; Rats, Inbred Strains; Ribonucleotides | 1976 |
Activation of heme oxygenase and heat shock protein 70 genes by stress in human hepatoma cells.
Topics: Arsenic; Arsenites; Cadmium; Cadmium Chloride; Carcinoma, Hepatocellular; Cell Line; Gene Expression Regulation; Heat-Shock Proteins; Heme; Heme Oxygenase (Decyclizing); Hot Temperature; Humans; Iodoacetamide; Kinetics; Liver Neoplasms; Mixed Function Oxygenases; RNA, Messenger; Sodium Compounds; Transcription, Genetic; Tumor Cells, Cultured | 1990 |
Endogenous forms of fibrinogen in Hep G2 cells.
Topics: Carcinoma, Hepatocellular; Cell Line; Fibrinogen; Humans; Iodoacetamide; Liver Neoplasms; Protein Conformation; Protein Precursors | 1987 |